This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiarelli, A. M. Articles by Boyd, N. F. Search for Related Content PubMed PubMed Citation Articles by Chiarelli, A. M. Articles by Boyd, N. F.

Influence of Patterns of Hormone Replacement Therapy Use and Mammographic Density on Breast Cancer Detection

¹ Division of Preventive Oncology, Cancer Care Ontario; ² Department of Public Health Sciences, University of Toronto; ³ Department of Radiology and Imaging Research, Sunnybrook and Women's College Health Science Centre; ⁴ Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Canada; and ⁵ Department of Epidemiology and Biostatistics, University of Western Ontario, London Canada

Requests for reprints: Anna M. Chiarelli, Division of Preventive Oncology, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7. Phone: 416-971-9800; Fax: 416-971-6888. E-mail: anna_chiarelli{at}cancercare.on.ca

Background: There is evidence that factors such as current hormone replacement therapy (HRT) use and mammographic density may each lower the sensitivity of mammography and are associated with a greater risk of developing an interval cancer. This study explores this relationship further by examining the influence of patterns of HRT use and the percentage of mammographic density on the detection of breast cancer by classification of interval cancer.

Methods: This study uses a case-case design nested within a cohort of women screened by the Ontario Breast Screening Program between 1994 and 2002. Interval cancers, both those missed at screening but seen on retrospective review (n = 87) or true intervals without visible tumor signs at screening (n = 288) were matched to 450 screen-detected cancers. The association between the percentage of mammographic density, measured by radiologists and a computer-assisted method, and HRT use, ascertained from a mailed questionnaire, and the risk of being diagnosed with an interval cancer was estimated using conditional logistic regression.

Results: A monotonic gradient of increasing risk for interval cancers was found for each 25% increase in mammographic density [odds ratio (OR), 1.77; 95% confidence intervals (95% CI), 1.07-2.95 for missed intervals and OR, 2.16; 95% CI, 1.59-2.94 for true intervals]. After adjusting for mammographic density, a significantly increased risk for true-interval cancers remained for women taking estrogen alone (OR, 1.75; 95% CI, 1.11-2.83) as well as for missed- (OR, 2.84; 95% CI, 1.32-6.13) and true-interval cancers (OR, 1.79; 95% CI, 1.10-2.90) for women taking combined HRT.

Conclusions: Information on mammographic density and HRT use should routinely be collected at the time of screening. Women at risk should be made aware of the lower sensitivity of mammography and offered alternative procedures for screening. (Cancer Epidemiol Biomarkers Prev 2006;15(10):1856–63)

This article has been cited by other articles:

				R. T. Chlebowski, G. Anderson, M. Pettinger, D. Lane, R. D. Langer, M. A. Gillian, B. W. Walsh, C. Chen, A. McTiernan, and for the Women's Health Initiative Investigators Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy Arch Intern Med, February 25, 2008; 168(4): 370 - 377. [Abstract] [Full Text] [PDF]